BRD2 and neoplasm: However, our data manifested that average sGRP78 levels during every round of NAT were irrelevant to the TNM stage, suggesting chemotherapy blurs the difference of serum sGRP78 among tumor burden and metastasis (Figure S1D, Supporting Information).